-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Arrowhead Pharma, Raises Price Target to $81

Benzinga·12/09/2025 18:00:01
語音播報
B of A Securities analyst Jason Gerberry maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and raises the price target from $62 to $81.